When prescribed and monitored appropriately, retatrutide is considered safe for many patients
NICE guidance (NG28) recommends: HbA1c monitoring every 36 months until stable, then 6-monthly Renal function tests at least annually (more frequently if pre-existing kidney disease) Weight and BMI tracking to assess treatment response Blood pressure monitoring , as weight loss may allow reduction in antihypertensive medications Appropriate retinopathy screening for patients with diabetes, particularly those with pre-existing retinopathy taking semaglutide Communication with your healthcare team is vital

Acute or short term side effects may include: Stomach or abdominal pain Nausea or stomach upset Indigestion Constipation Headache Dizziness Drowsiness Fatigue Tinnitus Fluid retention Long term side effects may include: Chronic stomach pain, heartburn, or nausea Increased risk of gastrointestinal bleeding Small bowel inflammation (1) Increased risk of stomach ulcers Increased risk of heart disease and cardiovascular events including heart attack, stroke, and heart failure Increased risk of kidney disease or kidney failure Neither of these are complete lists, and some people may be at a higher risk of experiencing serious side effects
It is also recommended for adults who want additional antioxidant support.Clinically effective dose in two easy-to-swallow softgels
doi:10.2147/DMSO.S193693 16
Think of it like a balloon: if it deflates slowly, it returns to its original shape more easily